EPHA2 and glioblastoma: EphA2 has been demonstrated to be elevated in 90% of cells of GBM but was not found to be so in normal brain tissue; additionally, it was expressed in a discordant manner to its associated ligand ephrinA1 in GBM, thus possibly demonstrating a role in the pathogenesis of this tumour [17].